| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| IMTXImmatics N.V. | 1.33B | 9.92 | 70.86 | 188.6% | -136.72% | -27.81% | 0.03 | |
| CTMXCytomX Therapeutics, Inc. | 720.1M | 4.25 | 11.18 | 36.45% | 24.66% | 26.09% | ||
| IOVAIovance Biotherapeutics, Inc. | 881.27M | 2.22 | -1.73 | 136.99% | -158.78% | -56.62% | 0.08 | |
| REPLReplimune Group, Inc. | 572.64M | 7.30 | -2.38 | -117.82% | 0.18 | |||
| NKTRNektar Therapeutics | 719.28M | 35.36 | -4.07 | 9.22% | -192.87% | -141.9% | 1.69 | |
| IMNMImmunome, Inc. | 2.52B | 22.85 | -4.57 | -35.5% | -23.01% | -84.4% | 0.03 | |
| IBRXImmunityBio, Inc. | 3.89B | 3.95 | -6.37 | 22.71% | -422.28% | |||
| NRIXNurix Therapeutics, Inc. | 1.91B | 18.86 | -6.55 | -29.15% | -292.5% | -65.76% | 0.05 |
| Dec 2016 | Dec 2017 | Dec 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 41.7M | 41.43M | 30.73M | 40.61M | 0 | 483.63K | 349.94K | 147.81K | 18.63K | 1M |
| Revenue Growth % | -0.02% | -0.01% | -0.26% | 0.32% | -1% | - | -0.28% | -0.58% | -0.87% | 52.69% |
| Cost of Goods Sold | 38.38M | 39.41M | 29.94M | 7.93M | 58.31K | 0 | 93.26K | 0 | 0 | 0 |
| COGS % of Revenue | 0.92% | 0.95% | 0.97% | 0.2% | - | - | 0.27% | - | - | - |
| Gross Profit | 3.33M | 2.03M | 791.11K | 32.68M | -58.31K | 483.63K | -21.09M | 147.81K | 18.63K | 0 |
| Gross Margin % | 0.08% | 0.05% | 0.03% | 0.8% | - | 1% | -60.28% | 1% | 1% | - |
| Gross Profit Growth % | -0.88% | -0.39% | -0.61% | 40.31% | -1% | 9.29% | -44.62% | 1.01% | -0.87% | -1% |
| Operating Expenses | 5.95M | 4.55M | 3.86M | 4.71M | 17.41M | 25.57M | 8.58M | 18.94M | 11.87M | 16.84M |
| OpEx % of Revenue | 0.14% | 0.11% | 0.13% | 0.12% | - | 52.87% | 24.5% | 128.14% | 637.18% | 16.84% |
| Selling, General & Admin | 5.95M | 4.55M | 3.86M | 2.51M | 7.53M | 8.94M | 8.58M | 7.13M | 6.13M | 8.49M |
| SG&A % of Revenue | 0.14% | 0.11% | 0.13% | 0.06% | - | 18.48% | 24.5% | 48.21% | 329.16% | 8.49% |
| Research & Development | 0 | 0 | 154.72K | 2.2M | 9.88M | 16.63M | 21.44M | 11.81M | 5.74M | 8.36M |
| R&D % of Revenue | - | - | 0.01% | 0.05% | - | 34.4% | 61.28% | 79.93% | 308.02% | 8.36% |
| Other Operating Expenses | 0 | 0 | 11.05M | 0 | 0 | 0 | -21.44M | 0 | 0 | 0 |
| Operating Income | -2.62M | -2.52M | -3.07M | -4.71M | -17.41M | -25.09M | -29.67M | -18.79M | -11.85M | -15.84M |
| Operating Margin % | -0.06% | -0.06% | -0.1% | -0.12% | - | -51.87% | -84.78% | -127.14% | -636.18% | -15.84% |
| Operating Income Growth % | 0.77% | 0.04% | -0.22% | -0.53% | -2.7% | -0.44% | -0.18% | 0.37% | 0.37% | -0.34% |
| EBITDA | -278.19K | -237.68K | -1.25M | -1.16M | -17.35M | -24.99M | -29.58M | -18.72M | -11.77M | -15.84M |
| EBITDA Margin % | -0.01% | -0.01% | -0.04% | -0.03% | - | -51.68% | -84.52% | -126.63% | -631.72% | -15.84% |
| EBITDA Growth % | 0.97% | 0.15% | -4.28% | 0.07% | -13.91% | -0.44% | -0.18% | 0.37% | 0.37% | -0.35% |
| D&A (Non-Cash Add-back) | 2.34M | 2.28M | 1.82M | 3.54M | 58.31K | 95.16K | 93.26K | 75.75K | 83.11K | 0 |
| EBIT | -1.8M | -5.22M | -5.52M | -16.7M | -24.27M | -25.09M | -29.67M | -18.79M | -11.85M | 0 |
| Net Interest Income | 0 | 0 | -381.68K | -162.87K | 0 | 15 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 20.68K | 15 | 0 | 0 | 0 | 0 |
| Interest Expense | -2.35M | -2.59M | 381.68K | 162.87K | 20.68K | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -1.53M | -5.29M | -7.38M | -162.87K | -6.85M | 103.47K | -52.48K | -40.08K | 4.41M | 51.03K |
| Pretax Income | -4.15M | -7.81M | -8.07M | -4.87M | -24.27M | -24.98M | -29.72M | -18.83M | -7.44M | -15.79M |
| Pretax Margin % | -0.1% | -0.19% | -0.26% | -0.12% | - | -51.66% | -84.93% | -127.42% | -399.29% | -15.79% |
| Income Tax | 198.46K | -644.43K | -701.22K | 162.87K | 0 | 0 | 0 | 0 | 0 | -218.4K |
| Effective Tax Rate % | 2.19% | 0.87% | 0.85% | 1% | 1% | 1% | 1% | 1% | 1% | 1.02% |
| Net Income | -9.08M | -6.79M | -6.85M | -4.87M | -24.27M | -25.01M | -29.77M | -18.83M | -7.44M | -16.11M |
| Net Margin % | -0.22% | -0.16% | -0.22% | -0.12% | - | -51.71% | -85.08% | -127.42% | -399.29% | -16.11% |
| Net Income Growth % | 0.25% | 0.25% | -0.01% | 0.29% | -3.98% | -0.03% | -0.19% | 0.37% | 0.61% | -1.17% |
| Net Income (Continuing) | -4.35M | -7.17M | -7.37M | -4.87M | -24.27M | -24.98M | -29.72M | -18.83M | -7.44M | 0 |
| Discontinued Operations | -4.81M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 791.42K | 782.45K | 827.04K | 827.04K | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -269068.00 | -175138.00 | -126904.00 | -163753.00 | -17159.00 | -2507.83 | -1203.05 | -145.12 | -11.35 | -3.95 |
| EPS Growth % | 0.51% | 0.35% | 0.28% | -0.29% | 0.9% | 0.85% | 0.52% | 0.88% | 0.92% | 0.65% |
| EPS (Basic) | -269068.00 | -175138.00 | -126904.00 | -163753.00 | -17159.00 | -2507.83 | -1203.05 | -145.12 | -11.35 | -3.95 |
| Diluted Shares Outstanding | 34 | 39 | 55 | 109 | 3.82K | 9.96K | 24.7K | 129.77K | 655.24K | 4.08M |
| Basic Shares Outstanding | 34 | 39 | 55 | 109 | 3.82K | 9.96K | 24.7K | 129.77K | 655.24K | 4.08M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.79M | 1.8M | 1.34M | 39.75K | 7.64M | 28.81M | 5.41M | 4.74M | 2.12M | 14.34M |
| Cash & Short-Term Investments | 268.57K | 438.49K | 524.11K | 35.65K | 7.35M | 27.62M | 3.05M | 2.27M | 149.46K | 5.12M |
| Cash Only | 268.57K | 438.49K | 524.11K | 35.65K | 7.35M | 27.62M | 3.05M | 2.27M | 149.46K | 5.12M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 524.48K | 475.99K | 325.36K | 223.96K | 0 | 0 | 717.3K | 786.57K | 762.08K | 0 |
| Days Sales Outstanding | 4.59 | 4.19 | 3.86 | 2.01 | - | - | 748.17 | 1.94K | 14.93K | - |
| Inventory | 539.55K | 460.76K | 335.21K | 354.34K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 5.13 | 4.27 | 4.09 | 16.3 | - | - | - | - | - | - |
| Other Current Assets | 461.07K | 589.84K | 159.21K | -578.3K | 0 | 0 | -717.3K | 1.68M | 0 | 9.22M |
| Total Non-Current Assets | 31.69M | 28.38M | 28.45M | 28.12M | 356.77K | 182.27K | 416.08K | 691.25K | 653.09K | 541.83K |
| Property, Plant & Equipment | 11.51M | 8.55M | 9.76M | 10.47M | 273.81K | 182.27K | 302.81K | 227.06K | 143.94K | 54.68K |
| Fixed Asset Turnover | 3.62x | 4.85x | 3.15x | 3.88x | - | 2.65x | 1.16x | 0.65x | 0.13x | 18.29x |
| Goodwill | 12.41M | 12.65M | 10.56M | 11.28M | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 18.94M | 18.54M | 15.03M | 5.12M | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 800K | 800K | 800K | 800K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 442.74K | 490.33K | 2.86M | 446.64K | 82.96K | 0 | 113.28K | 464.19K | 509.15K | 487.15K |
| Total Assets | 33.49M | 30.18M | 29.79M | 39.75K | 7.99M | 28.99M | 5.83M | 5.43M | 2.77M | 14.88M |
| Asset Turnover | 1.25x | 1.37x | 1.03x | 1021.63x | - | 0.02x | 0.06x | 0.03x | 0.01x | 0.07x |
| Asset Growth % | -0.21% | -0.1% | -0.01% | -1% | 200.1% | 2.63% | -0.8% | -0.07% | -0.49% | 4.37% |
| Total Current Liabilities | 12.11M | 14.73M | 13.03M | 2.89M | 4.72M | 6.7M | 8.16M | 5.52M | 3.21M | 4.1M |
| Accounts Payable | 3.81M | 3.68M | 2.38M | 1.84M | 2.06M | 3.78M | 4.75M | 2.2M | 2.18M | 2.94M |
| Days Payables Outstanding | 36.22 | 34.07 | 29.03 | 84.79 | 12.88K | - | 18.6K | - | - | - |
| Short-Term Debt | 6.38M | 8.74M | 6.66M | 217.38K | 21.18K | 748 | 748 | 73.05K | 0 | 46.57K |
| Deferred Revenue (Current) | 173.78K | 83.88K | 1000K | 983.49K | 500K | 516.37K | 166.43K | 18.63K | 0 | 0 |
| Other Current Liabilities | 1.67M | 2.4M | 3.97M | -983.49K | 1.42M | 1.32M | 1.98M | 1.07M | 151.63K | 4.05M |
| Current Ratio | 0.15x | 0.12x | 0.10x | 0.01x | 1.62x | 4.30x | 0.66x | 0.86x | 0.66x | 3.50x |
| Quick Ratio | 0.10x | 0.09x | 0.08x | -0.11x | 1.62x | 4.30x | 0.66x | 0.86x | 0.66x | 3.50x |
| Cash Conversion Cycle | -26.5 | -25.61 | -21.08 | -66.48 | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.41M | 3.96M | 8.51M | 17.71M | 250.01K | 30.61K | 203.91K | 130.86K | 46.57K | 0 |
| Long-Term Debt | 3.97M | 852.38K | 3.67M | 15.91M | 124.88K | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | -175K | 0 | 15.91M | 125.13K | 30.61K | 203.91K | 130.86K | 46.57K | 0 |
| Deferred Tax Liabilities | 1.49M | 779.36K | 76.77K | 119.92K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.96M | 2.16M | 3.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 19.52M | 18.69M | 21.54M | 2.89M | 4.97M | 6.73M | 8.37M | 5.66M | 3.26M | 4.1M |
| Total Debt | 10.35M | 9.59M | 10.34M | 217.38K | 353.25K | 125.88K | 255.99K | 203.91K | 130.86K | 46.57K |
| Net Debt | 10.08M | 9.16M | 9.81M | 181.73K | -7M | -27.5M | -2.8M | -2.07M | -18.59K | -5.07M |
| Debt / Equity | 0.76x | 0.84x | 1.25x | - | 0.12x | 0.01x | - | - | - | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | -8.05x | -28.91x | -842.06x | - | - | - | - | - |
| Total Equity | 13.61M | 11.49M | 8.26M | -2.02M | 3.02M | 22.26M | -2.54M | -225.98K | -485.74K | 10.79M |
| Equity Growth % | -0.39% | -0.16% | -0.28% | -1.24% | 2.5% | 6.37% | -1.11% | 0.91% | -1.15% | 23.21% |
| Book Value per Share | 401983.49 | 291490.32 | 150281.61 | -18528.84 | 789.93 | 2234.48 | -102.76 | -1.74 | -0.74 | 2.64 |
| Total Shareholders' Equity | 12.82M | 10.71M | 7.43M | -2.85M | 3.02M | 22.26M | -2.54M | -225.98K | -485.74K | 10.79M |
| Common Stock | 2.14K | 305 | 373 | 555 | 1.47K | 6.03K | 554 | 175 | 65 | 708 |
| Retained Earnings | -42.21M | -49.11M | -57.12M | -12.44M | -36.71M | -61.69M | -91.41M | -110.24M | -117.68M | -133.69M |
| Treasury Stock | -55.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.16M | -934.9K | -202.12K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 791.42K | 782.45K | 827.04K | 827.04K | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Dec 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -509.16K | -724.43K | -1.11M | -2.23M | -15.61M | -22.55M | -27.69M | -21.34M | -8.61M | -12.83M |
| Operating CF Margin % | -0.01% | -0.02% | -0.04% | -0.05% | - | -46.63% | -79.12% | -144.39% | -462.13% | -12.83% |
| Operating CF Growth % | 0.91% | -0.42% | -0.53% | -1.01% | -6.02% | -0.44% | -0.23% | 0.23% | 0.6% | -0.49% |
| Net Income | -4.27M | -6.79M | -6.86M | -5.03M | -24.27M | -24.98M | -29.72M | -18.83M | -7.44M | -16.01M |
| Depreciation & Amortization | 2.34M | 2.28M | 1.82M | 2.16M | 58.31K | 95.16K | 93.26K | 75.75K | 83.11K | 89.26K |
| Stock-Based Compensation | 0 | 0 | 0 | 430K | 370.06K | 1.38M | 876.37K | 248.63K | 231.19K | 199.59K |
| Deferred Taxes | 131.78K | -706.2K | -779.36K | -702.59K | 0 | -125.5K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 4.71M | 6.66M | 3.03M | -1.21M | 6.83M | 623 | 971.48K | 282K | 384.16K | 2.9M |
| Working Capital Changes | 25.23K | 1.31M | 2.62M | 2.13M | 1.4M | 1.09M | 93.46K | -3.12M | -1.87M | 0 |
| Change in Receivables | -336.55K | 35.15K | 114.01K | 91.8K | 0 | 0 | 0 | -69.27K | 24.5K | 0 |
| Change in Inventory | 33.22K | 23.06K | 72.8K | 8.88K | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.54M | 1.04M | 2.51M | 1.39M | 168.81K | 1.72M | 971.04K | -2.63M | 48.42K | 630.38K |
| Cash from Investing | -430.82K | -439.3K | -1.25M | -2.44M | -76.18K | -3.62K | -896.48K | -443.25K | -12K | -12K |
| Capital Expenditures | -1.19M | -1.63M | -1.7M | -2.39M | -76.18K | -3.62K | -896.48K | -443.25K | -12K | 0 |
| CapEx % of Revenue | 0.03% | 0.04% | 0.06% | 0.06% | - | 0.01% | 2.56% | 3% | 0.64% | - |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 461.16K | -322.28K | -1.49M | 0 | 0 | 0 | 0 | 0 | -12K |
| Cash from Financing | -21.98K | 1.36M | 1.32M | 2.26M | 23.01M | 42.83M | 4.01M | 21.01M | 6.49M | 26.05M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 0 | 0 | 383.08K | -526.06K | 3.81M | 0 | 0 | 849 | 2.6M | 26.05M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -1.7M | -2.35M | -2.81M | -4.62M | -15.69M | -22.56M | -28.58M | -21.79M | -8.61M | -12.83M |
| FCF Margin % | -0.04% | -0.06% | -0.09% | -0.11% | - | -46.64% | -81.68% | -147.39% | -462.13% | -12.83% |
| FCF Growth % | 0.76% | -0.38% | -0.2% | -0.64% | -2.4% | -0.44% | -0.27% | 0.24% | 0.6% | -0.49% |
| FCF per Share | -50209.69 | -59620.31 | -51110.72 | -42397.26 | -4104.36 | -2264.19 | -1157.00 | -167.87 | -13.14 | -3.14 |
| FCF Conversion (FCF/Net Income) | 0.06x | 0.11x | 0.16x | 0.46x | 0.64x | 0.90x | 0.93x | 1.13x | 1.16x | 0.80x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -50.76% | -54.14% | -69.42% | -156.15% | -4845.91% | -197.83% | -301.95% | - | - | -312.81% |
| Return on Invested Capital (ROIC) | -7.33% | -8.53% | -11.9% | -43.5% | - | - | - | - | - | -456.2% |
| Gross Margin | 7.98% | 4.89% | 2.57% | 80.47% | - | 100% | -6027.86% | 100% | 100% | - |
| Net Margin | -21.77% | -16.4% | -22.3% | -11.99% | - | -5170.52% | -8508.34% | -12741.58% | -39929.3% | -1611.27% |
| Debt / Equity | 0.76x | 0.84x | 1.25x | - | 0.12x | 0.01x | - | - | - | 0.00x |
| Interest Coverage | - | - | -8.05x | -28.91x | -842.06x | - | - | - | - | - |
| FCF Conversion | 0.06x | 0.11x | 0.16x | 0.46x | 0.64x | 0.90x | 0.93x | 1.13x | 1.16x | 0.80x |
| Revenue Growth | -1.64% | -0.65% | -25.82% | 32.15% | -100% | - | -27.64% | -57.76% | -87.4% | 5268.84% |
| 2012 | 2013 | 2014 | 2015 | 2016 | |
|---|---|---|---|---|---|
| Better Burgers Fast Casual | - | - | - | 14.54M | 22.59M |
| Better Burgers Fast Casual Growth | - | - | - | - | 55.33% |
| Hooters Full Service | - | - | - | 21.93M | 13.33M |
| Hooters Full Service Growth | - | - | - | - | -39.22% |
| Just Fresh Fast Casual | - | - | - | 5.5M | 5.68M |
| Just Fresh Fast Casual Growth | - | - | - | - | 3.38% |
| Corporate and Other | - | - | - | 424.83K | 100K |
| Corporate and Other Growth | - | - | - | - | -76.46% |
| 2012 | 2013 | 2014 | 2015 | 2016 | |
|---|---|---|---|---|---|
| United States | - | - | - | 25.53M | 33.37M |
| United States Growth | - | - | - | - | 30.74% |
| South Africa | 6.28M | - | - | - | 5.41M |
| South Africa Growth | - | - | - | - | - |
| Europe | - | 1.52M | 4.66M | 3.98M | 2.92M |
| Europe Growth | - | - | 206.09% | -14.43% | -26.78% |
| AUSTRALIA | - | - | 5.61M | 6.45M | - |
| AUSTRALIA Growth | - | - | - | 14.96% | - |
| SOUTH AFRICA | - | 5.74M | 6.63M | 6.43M | - |
| SOUTH AFRICA Growth | - | - | 15.56% | -3.04% | - |
| UNITED STATES | - | 987.28K | 12.94M | - | - |
| UNITED STATES Growth | - | - | 1210.83% | - | - |
| Hungary | 468.14K | - | - | - | - |
| Hungary Growth | - | - | - | - | - |
Sonnet BioTherapeutics Holdings, Inc. (SONN) reported $1.0M in revenue for fiscal year 2025. This represents a 32% decrease from $1.5M in 2011.
Sonnet BioTherapeutics Holdings, Inc. (SONN) grew revenue by 5268.8% over the past year. This is strong growth.
Sonnet BioTherapeutics Holdings, Inc. (SONN) reported a net loss of $13.6M for fiscal year 2025.
Sonnet BioTherapeutics Holdings, Inc. (SONN) has a return on equity (ROE) of -312.8%. Negative ROE indicates the company is unprofitable.
Sonnet BioTherapeutics Holdings, Inc. (SONN) had negative free cash flow of $10.3M in fiscal year 2025, likely due to heavy capital investments.